Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Osong Public Health and Research Perspectives ; (6): 271-274, 2017.
Article in English | WPRIM | ID: wpr-650995

ABSTRACT

OBJECTIVES: The aim of this study was to determine whether exercises can change the cervical angle and respiratory function in smartphone users. METHODS: Thirty healthy volunteers were recruited. The subjects were randomly divided into an exercise group and a control group. All participants used a smartphone for 1 hour while maintaining a sitting posture. Then, each group performed their assigned activity. The exercise group performed two types of exercises and the control group maintained routine activities for 20 minutes. To investigate the changes in cervical angle and respiratory function, we measured the craniovertebral angle by using a spirometer. RESULTS: Statistically significant differences were noted in the craniovertebral angle, forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio, peak expiratory flow, maximal inspiratory pressure, and maximal expiratory pressure of the two groups (p < 0.05). CONCLUSION: Our findings showed that proper exercise could be a good method of improving the cervical angle and respiratory function in smartphone users.


Subject(s)
Female , Cervical Vertebrae , Exercise , Forced Expiratory Volume , Healthy Volunteers , Methods , Posture , Respiratory Function Tests , Smartphone , Vital Capacity
2.
Korean Journal of Obstetrics and Gynecology ; : 1097-1100, 2002.
Article in Korean | WPRIM | ID: wpr-171437

ABSTRACT

High-risk gestational choriocarcinoma in patients who have failed primary chemotherapy is known to have a very poor prognosis. About 25% of high-risk metastatic choriocarcinoma become refractory to EMACO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) and fail to achieve a complete remission. Currently, there is no standard salvage chemotherapeutic regimen for EMACO refractory choriocarcinoma. Paclitaxel, a taxane analog extracted from the bark of the western yew, has shown antitumor activity in a variety of cancers. However, there has been few case reports that described the effectiveness of paclitaxel to choriocarcinoma. We describe a 41-year old woman with refractory choriocarcinoma, who demonstrated dramatic response to paclitaxel treatment with a brief review of literature.


Subject(s)
Adult , Female , Humans , Pregnancy , Choriocarcinoma , Cyclophosphamide , Dactinomycin , Drug Therapy , Methotrexate , Paclitaxel , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL